Skip to main navigation Skip to search Skip to main content

Correction: The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells [Breast Cancer Res. 8, 4, (2006) (R46)] DOI: 10.1186/bcr1533

  • Ma'anit Shapira
  • , Eli Kakiashvili
  • , Tzur Rosenberg
  • , Dan D. Hershko
  • Rambam Health Care Campus Israel
  • Technion-Israel Institute of Technology

Research output: Contribution to journalComment/debate

3 Scopus citations

Abstract

After the publication of this work [1], an error was noticed in Fig. 2b, Fig. 3a and Fig. 5b. The Skp1 loading control was accidentally duplicated. We apologize for this error, which did not affect any of the interpretations or conclusions of the article.

Original languageEnglish
Article number68
JournalBreast Cancer Research
Volume20
Issue number1
DOIs
StatePublished - 9 Jul 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2018 The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction: The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells [Breast Cancer Res. 8, 4, (2006) (R46)] DOI: 10.1186/bcr1533'. Together they form a unique fingerprint.

Cite this